2025 first_quarter Filing
Q1Lobbying Activities (2)
Medicare/Medicaid
View allMonitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Telehealth extension; Issues related to Medicare Advantage provider directories, marketing practices, prior authorization; Issues related to 2025 Medicare Part D Bid Information and Announces Premium Stabilization Demonstration; Calendar Year (CY) 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) Programs (Rate Notice); Issues related to the use of AI and its correlation to prior authorization and utilization management policies
Health Issues
View allS. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4)